Literature DB >> 8813953

Accuracy of staging in primary biliary cirrhosis.

M C Garrido1, S G Hubscher.   

Abstract

AIMS: To evaluate sampling variability of liver biopsy in patients with primary biliary cirrhosis (PBC).
METHODS: Sections from 50 PBC liver specimens obtained at transplantation were examined. The degree of fibrosis was assessed on a scale of 0-4 using two methods: (1) simulated needle biopsy in fields approximately the size of conventional needle biopsy; and (2) whole section scanning in areas with little and extensive fibrosis.
RESULTS: Considerable variation in the range of stages of fibrosis was found when the whole section scanning method was used. Only 10 (20%) samples had a consistent degree of fibrosis in all sections scanned. By contrast, the same fibrosis stage was assigned in 30 (60%) specimens examined using the simulated needle biopsy method. When the results obtained by the two methods were compared, there was a discrepancy of one or two stages in 32 samples. This discrepancy was the result of discovering areas with a lesser degree of fibrosis in whole sections compared with the simulated needle biopsy specimens.
CONCLUSION: There is considerable variation in the degree of fibrosis in the livers of patients with PBC, even when end stage specimens obtained at transplantation are examined. Consistent results were obtained when simulated needle biopsy specimens were examined. This, however, may be a reflection of the procedure applied when staging liver needle biopsy specimens, where the greatest degree of abnormality is used in determining the stage. The practice of staging of PBC in small needle biopsy specimens is valuable as long as the appearances are interpreted with caution, bearing in mind that there is considerable variability in the degree of fibrosis.

Entities:  

Mesh:

Year:  1996        PMID: 8813953      PMCID: PMC500569          DOI: 10.1136/jcp.49.7.556

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  9 in total

1.  PRIMARY BILIARY CIRRHOSIS. CHRONIC NON-SUPPURATIVE DESTRUCTIVE CHOLANGITIS.

Authors:  E RUBIN; F SCHAFFNER; H POPPER
Journal:  Am J Pathol       Date:  1965-03       Impact factor: 4.307

2.  Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis).

Authors:  J Ludwig; E R Dickson; G S McDonald
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1978-08-22

Review 3.  Nonsuppurative destructive chronic cholangitis and chronic hepatitis.

Authors:  H Popper; F Schaffner
Journal:  Prog Liver Dis       Date:  1970

4.  Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver.

Authors:  B Maharaj; R J Maharaj; W P Leary; R M Cooppan; A D Naran; D Pirie; D J Pudifin
Journal:  Lancet       Date:  1986-03-08       Impact factor: 79.321

5.  Sampling variability of percutaneous liver biopsy in primary sclerosing cholangitis.

Authors:  R Olsson; I Hägerstrand; U Broomé; A Danielsson; G Järnerot; L Lööf; H Prytz; B O Rydén; S Wallerstedt
Journal:  J Clin Pathol       Date:  1995-10       Impact factor: 3.411

6.  Referral of patients with primary biliary cirrhosis for liver transplantation.

Authors:  J M Neuberger; B K Gunson; J A Buckels; E Elias; P McMaster
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

7.  Primary biliary cirrhosis.

Authors:  P Scheuer
Journal:  Proc R Soc Med       Date:  1967-12

8.  Application of the Mayo primary biliary cirrhosis survival model to Mayo liver transplant patients.

Authors:  P M Grambsch; E R Dickson; R H Wiesner; A Langworthy
Journal:  Mayo Clin Proc       Date:  1989-06       Impact factor: 7.616

9.  Sampling variability on percutaneous liver biopsy.

Authors:  W Abdi; J C Millan; E Mezey
Journal:  Arch Intern Med       Date:  1979-06
  9 in total
  16 in total

1.  Right hepatic lobectomy for hepatocellular carcinoma which developed in primary biliary cirrhosis: report of a case.

Authors:  T Morimoto; G Honda; Y Kawai; T Hirose; T Nishio; N Shinkura; Y Iimuro; N Yamamoto; Y Yamamoto; I Ikai; Y Shimahara; Y Yamaoka
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

2.  Integrative role of MRI in the evaluation of primary biliary cirrhosis.

Authors:  Jelena Djokić Kovač; Rada Ješić; Dejana Stanisavljević; Bojan Kovač; Bojan Banko; Petar Seferović; Ružica Maksimović
Journal:  Eur Radiol       Date:  2011-10-12       Impact factor: 5.315

3.  The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines.

Authors:  Gideon M Hirschfield; Jessica K Dyson; Graeme J M Alexander; Michael H Chapman; Jane Collier; Stefan Hübscher; Imran Patanwala; Stephen P Pereira; Collette Thain; Douglas Thorburn; Dina Tiniakos; Martine Walmsley; George Webster; David E J Jones
Journal:  Gut       Date:  2018-03-28       Impact factor: 23.059

4.  Identification of Helicobacter pylori and other Helicobacter species by PCR, hybridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis.

Authors:  H O Nilsson; J Taneera; M Castedal; E Glatz; R Olsson; T Wadström
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

5.  Antipyrine clearance and metabolite formation in primary biliary cirrhosis.

Authors:  F Jorquera; M Almar; A Linares; J L Olcóz; L Rodrigo; J González-Gallego
Journal:  Dig Dis Sci       Date:  2001-02       Impact factor: 3.199

6.  Risk factors for hepatic decompensation in patients with primary biliary cirrhosis.

Authors:  Tian-Yan Shi; Li-Na Zhang; Hua Chen; Li Wang; Min Shen; Xuan Zhang; Feng-Chun Zhang
Journal:  World J Gastroenterol       Date:  2013-02-21       Impact factor: 5.742

7.  Measurement and determinants of the natural history of liver fibrosis in hepatitis C virus infection: a cross sectional and longitudinal study.

Authors:  M Wright; R Goldin; A Fabre; J Lloyd; H Thomas; C Trepo; P Pradat; M Thursz
Journal:  Gut       Date:  2003-04       Impact factor: 23.059

8.  Current and emerging surrogate markers of hepatic fibrosis in primary biliary cirrhosis.

Authors:  Jayant A Talwalkar
Journal:  Liver Int       Date:  2008-07       Impact factor: 5.828

9.  The value of MRI in the diagnosis of primary biliary cirrhosis and assessment of liver fibrosis.

Authors:  Ying Meng; Yuting Liang; Mingming Liu
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

10.  Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay.

Authors:  Marlyn J Mayo; Julie Parkes; Beverley Adams-Huet; Burton Combes; A S Mills; Rodney S Markin; Raphael Rubin; Donald Wheeler; Melissa Contos; A B West; Sandra Saldana; Yonas Getachew; Robert Butsch; Velimir Luketic; Marion Peters; Adrian Di Bisceglie; Nathan Bass; John Lake; Thomas Boyer; Enrique Martinez; James Boyer; Guadalupe Garcia-Tsao; David Barnes; William M Rosenberg
Journal:  Hepatology       Date:  2008-11       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.